High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury

High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury

PurposeMyocardial injury, as a serious complication of coronavirus disease-2019 (COVID-19), increases the occurrence of adverse outcomes. Identification of key regulatory molecules of myocardial injury may help formulate corresponding treatment strategies and improve the prognosis of COVID-19 patien...

Full description

Bibliographic Details
Main Authors:	Tingting Chen, Haixin Chen, Ping Chen, Linchao Zhu, Wei Mao, Yimin Yao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Immunology
Subjects:	interleukin signal pathway lymphocyte subsets coronavirus disease-2019 myocardial injury interleukin 6 high-sensitivity troponin
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1190644/full

Similar Items

Dynamic profile and clinical implications of hematological and immunological parameters in COVID-19 patients. A retrospective study
by: Shekhar Yashwant Suryawanshi, et al.
Published: (2021-01-01)

An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study
by: Maria Elena Laino, et al.
Published: (2022-01-01)

Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer
by: Yingying Yu, et al.
Published: (2022-06-01)

Clinical characteristics of coronavirus disease 2019 in a Chongqing hospital: analysis of 89 cases
by: HUANG Chengcheng, et al.
Published: (2020-05-01)

Assessment of interleukin-6 role in detecting coronavirus disease 2019 severity, mortality, and its control: A cohort study
by: Heba M Shalaby, et al.
Published: (2023-01-01)

2020 Updates on tocilizumab indications for clinicians managing patients with severe acute respiratory syndrome coronavirus 2
by: Mohammed A Omair, et al.
Published: (2020-01-01)

Letter to the Editor in response to Chen et al. 2020
by: Jaya Ponnampalam, et al.
Published: (2020-11-01)

Relationship between chest CT manifestations and immune response in COVID-19 patients
by: Susu He, et al.
Published: (2020-09-01)

Influence of renin-angiotensin-aldosterone system block on the systemic inflammation activity and left ventricle remodeling in patients with Q-myocardial infarction after thrombolysis
by: S. M. Kyselov
Published: (2015-06-01)

Correlation of lymphocyte subsets and inflammatory biomarkers with disease severity in COVID-19 patients
by: Khawar Abbas, et al.
Published: (2023-12-01)

Prognostic implications of serial high-sensitivity cardiac troponin testing among patients with COVID-19: A Danish nationwide registry-based cohort study
by: Christoffer Polcwiartek, et al.
Published: (2022-02-01)

Association of Inflammatory Biomarkers with COVID-19 Disease Severity at Tertiary Care Hospital, Mumbai, India
by: Trupti Ramteke, et al.
Published: (2021-10-01)

The characteristics and predictive role of lymphocyte subsets in COVID-19 patients
by: Wenjing Zhang, et al.
Published: (2020-10-01)

Effect of ulinastatin on early inflammatory and T lymphocyte immune responses in patients with severe multiple trauma and its clinical value
by: LIU Han, et al.
Published: (2019-09-01)

Potential Predictors for Serofast State after Treatment among HIV-Negative Persons with Syphilis in China: A Systematic Review and Meta-Analysis
by: Jiabi Qin, et al.
Published: (2015-02-01)

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
by: Camilla Huse, et al.
Published: (2022-06-01)

Clinical characteristics and outcomes of critically ill mechanically ventilated COVID-19 patients receiving interleukin-6 receptor antagonists and corticosteroid therapy: a preliminary report from a multinational registry
by: Marwa Amer, et al.
Published: (2021-10-01)

The Ratio of IL-6 to IL-4 in Synovial Fluid of Knee or Hip Performances a Noteworthy Diagnostic Value in Prosthetic Joint Infection
by: Xudong Su, et al.
Published: (2022-11-01)

Effects of Huaiqihuang Granules adjuvant therapy in children with primary nephrotic syndrome
by: Zhou Ping, et al.
Published: (2019-12-01)

Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction
by: Marc Jonathan George, MB ChB, PhD, et al.
Published: (2021-05-01)

IL‐38 attenuates myocardial ischemia–reperfusion injury by inhibiting macrophage inflammation
by: Yuzhen Wei, et al.
Published: (2023-06-01)

Fatigue in Older Adults Post Myocardial Infarction
by: Patricia Barton Crane, et al.
Published: (2016-04-01)

Evaluation of IL-3, IL-5, and IL-6 concentration in the follicular fluid of women with endometriosis: A cross-sectional study
by: Mohammad Ghodsi, et al.
Published: (2022-03-01)

Sarilumab use in severe Coronavirus Disease 2019 pneumonia
by: Ahmed M.A. El Fattah Amer, et al.
Published: (2023-01-01)

Targeting IL-6 Trans-Signaling
by: Pål Aukrust, MD, PhD, et al.
Published: (2021-05-01)

Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool
by: Sara Momtazmanesh, et al.
Published: (2020-07-01)

Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10
by: Yu-Dong Rong, et al.
Published: (2018-12-01)

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
by: Tao Liu, et al.
Published: (2020-07-01)

Role of interleukin-6 in coronavirus disease 2019 pneumonia: sensitive marker of inflammation, a predictor of ventilatory support and early marker of post-coronavirus disease lung fibrosis. A single center experience
by: Shital Patil, et al.
Published: (2023-01-01)

Aminothiols exchange in coronavirus disease 2019
by: Viktorovna Fefelova Elena, et al.
Published: (2023-01-01)

Predictors of Mortality in Patients of COVID-19 Pneumonia in Intensive Care Unit: An Observational Study in a Tertiary Care Hospital, Lucknow, India
by: Hemant Kumar, et al.
Published: (2021-08-01)

Peripheral Inflammatory Factors and Acute Myocardial Infarction Risk: A Mendelian Randomization Study
by: Yaxi Chen, et al.
Published: (2023-10-01)

Decreased Expression of Leptin among Patients with Shoulder Stiffness
by: Jih-Yang Ko, et al.
Published: (2022-10-01)

The potential of IFN-λ, IL-32γ, IL-6, and IL-22 as safeguards against human viruses: a systematic review and a meta-analysis
by: Areej A. Sattar, et al.
Published: (2024-02-01)

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction
by: Vibeke N. Ritschel, et al.
Published: (2016-06-01)

Role of Inflammation in Cardiac Remodeling After Acute Myocardial Infarction
by: Francisco A. Fonseca, et al.
Published: (2022-06-01)

ASSOCIATION OF IL-1β, IL-4 AND IL-6 GENES POLYMORPHISMS WITH GENETIC PREDISPOSITION FOR AUTOIMMUNE THYROIDITIS
by: E. M. Biktagirova, et al.
Published: (2014-07-01)

Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial
by: Martin Benedikt, et al.
Published: (2023-07-01)

GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis
by: Xiaomiao Ye, et al.
Published: (2022-09-01)

PCT, IL-6, and IL-10 facilitate early diagnosis and pathogen classifications in bloodstream infection
by: Xianggui Yang, et al.
Published: (2023-11-01)